Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent

Academic Radiology
H FountaineB H Grynne

Abstract

A review of clinical-chemical parameters and tolerability of iodixanol is presented. Iodixanol is a newly developed dimeric, ratio 6 radiographic contrast medium formulated to be isotonic to plasma in all concentrations by the balanced addition of electrolytes. We summarize completed trials of iodixanol. The increase in femoral blood flow following administration of iodixanol was significantly smaller than that seen with most other nonionic contrast media. Iodixanol appears to have less impact than other nonionic media on renal tubular function. Unlike iohexol and ioxaglate, the rate of adverse events after iodixanol administration was essentially the same for normal patients as for patients at increased risk for negative reactions (patients with previous adverse reactions to contrast administration). The risk following administration of iodixanol also appears to be similar in normal patients and in patients with other risk factors, including those with a history of congestive heart failure, renal insufficiency or disease, asthma, diabetes, hypertension, or vascular disease. A significant reduction in the sensation of injection-associated heat and pain was noted for iodixanol versus ioxaglate. Cardiac electrophysiologic measure...Continue Reading

References

Nov 1, 1978·Investigative Radiology·M J LiptonW H Barry
Feb 1, 1992·Investigative Radiology·M G SvalandP A Hals
Aug 1, 1991·Journal of the American College of Cardiology·J A Brinker
Apr 1, 1991·Catheterization and Cardiovascular Diagnosis·M A TaylorA R Gear
Mar 1, 1990·Catheterization and Cardiovascular Diagnosis·C J MurdockG D Cope
Feb 1, 1989·AJR. American Journal of Roentgenology·P RasuliD I Hammond
Jan 1, 1988·Catheterization and Cardiovascular Diagnosis·J H GrollmanM D Lurie
Feb 1, 1985·Journal of the American College of Cardiology·E W GertzC Hu
Mar 1, 1986·Investigative Radiology·P DawsonA Bradshaw
Sep 1, 1972·Circulation·F E KlosterM P Judkins
Nov 1, 1984·Investigative Radiology·D C Cumberland
Mar 1, 1981·The American Journal of Cardiology·H YamazakiR H Helfant
Jun 1, 1983·Radiology·C GosposX Papacharlampos
Jun 1, 1994·Investigative Radiology·P P HarnishR Ebrahimi
Jul 1, 1994·The American Journal of Cardiology·J A HillJ A Brinker
Jan 1, 1964·Radiology·G G GENSINI, S DIGIORGI

❮ Previous
Next ❯

Citations

Apr 8, 2011·European Journal of Radiology·Shinn-Huey ChouBenjamin M Yeh
Mar 31, 2009·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Mehmet ColbayOguz Aslan Ozen
May 15, 2012·Pharmacological Reports : PR·Amrit Pal SinghRavi Dhawan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved